IOL Chemicals and Pharmaceuticals Limited

NSEI:IOLCP Rapporto sulle azioni

Cap. di mercato: ₹24.0b

IOL Chemicals and Pharmaceuticals Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del management9.4yrs
Durata media del Consiglio di amministrazione3.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Investors Still Aren't Entirely Convinced By IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Earnings Despite 26% Price Jump

Dec 20
Investors Still Aren't Entirely Convinced By IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Earnings Despite 26% Price Jump

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Has A Somewhat Strained Balance Sheet

Nov 19
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Has A Somewhat Strained Balance Sheet

A Piece Of The Puzzle Missing From IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Share Price

Sep 11
A Piece Of The Puzzle Missing From IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Share Price

Is There An Opportunity With IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) 34% Undervaluation?

Jun 12
Is There An Opportunity With IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) 34% Undervaluation?

Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Aug 30
Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Has A Pretty Healthy Balance Sheet

May 18
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Has A Pretty Healthy Balance Sheet

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Will Pay A Dividend Of ₹4.00

Feb 10
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Will Pay A Dividend Of ₹4.00

Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Jun 07
Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Calculating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

May 07
Calculating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Do IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Warrant Your Attention?

May 04
Do IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Warrant Your Attention?

Is IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) An Attractive Dividend Stock?

Mar 13
Is IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) An Attractive Dividend Stock?

Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Feb 23
Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Should You Rely On IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) Earnings Growth?

Feb 08
Should You Rely On IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) Earnings Growth?

IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 27
IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

How Does IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Salary Compare to Peers?

Jan 15
How Does IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Salary Compare to Peers?

Estimating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Jan 02
Estimating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Shareholders of IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Must Be Delighted With Their 869% Total Return

Dec 21
Shareholders of IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Must Be Delighted With Their 869% Total Return

Is Now The Time To Put IOL Chemicals and Pharmaceuticals (NSE:IOLCP) On Your Watchlist?

Dec 09
Is Now The Time To Put IOL Chemicals and Pharmaceuticals (NSE:IOLCP) On Your Watchlist?

These 4 Measures Indicate That IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Is Using Debt Reasonably Well

Nov 24
These 4 Measures Indicate That IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Is Using Debt Reasonably Well

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Could Be A Buy For Its Upcoming Dividend

Nov 12
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Could Be A Buy For Its Upcoming Dividend

Is There More To The Story Than IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Growth?

Nov 09
Is There More To The Story Than IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Growth?

Will Weakness in IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Stock Prove Temporary Given Strong Fundamentals?

Oct 27
Will Weakness in IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Stock Prove Temporary Given Strong Fundamentals?

Here's What We Think About IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Pay

Oct 09
Here's What We Think About IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Pay

Calculating The Fair Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Sep 18
Calculating The Fair Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Here's Why I Think IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Might Deserve Your Attention Today

Sep 03
Here's Why I Think IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Might Deserve Your Attention Today

Cautious Investors Not Rewarding IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Performance Completely

Aug 16
Cautious Investors Not Rewarding IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Performance Completely

AMMINISTRATORE DELEGATO

IOL Chemicals and Pharmaceuticals non ha un CEO, o non abbiamo dati su di loro.

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Pardeep Khanna
Chief Financial Officer9.4yrs₹15.80mNessun dato
Abhay Singh
VP, Company Secretary & Compliance Officer5.2yrs₹7.40mNessun dato
Varinder Gupta
MD & Whole Time Director17.3yrs₹98.57m2.04%
₹ 490.3m
Vikas Gupta
Joint Managing Director & Executive Director9.7yrs₹30.06mNessun dato
Kushal Rana
Director of Works & Wholetime Directorno data₹17.07mNessun dato
Abhiraj Gupta
Executive Director1.8yrs₹12.99mNessun dato
Gurupur Pai
Chief Technology Officerno dataNessun datoNessun dato
Damandeep Singh
President of Projectno data₹780.00kNessun dato
Kamlesh Ranbhan
President of R&Dno dataNessun datoNessun dato
Gopal Singla
President of Engineeringno dataNessun datoNessun dato
Praveen Hans
President of API Businessno dataNessun datoNessun dato

9.4yrs

Durata media

54yo

Età media

Gestione esperta: Il team dirigenziale di IOLCP è esperto e expertise (durata media dell'incarico 9.4 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Varinder Gupta
MD & Whole Time Director18.6yrs₹98.57m2.04%
₹ 490.3m
Vikas Gupta
Joint Managing Director & Executive Director1.8yrs₹30.06mNessun dato
Kushal Rana
Director of Works & Wholetime Director3.6yrs₹17.07mNessun dato
Abhiraj Gupta
Executive Director1.8yrs₹12.99mNessun dato
Rajender Malla
Independent Chairman of the Board5.9yrs₹500.00kNessun dato
Sharad Tyagi
Additional Independent Director2.7yrs₹1.15mNessun dato
Harpal Singh
Independent Director5.9yrs₹750.00kNessun dato
Rajni Jha
Woman Independent Directorless than a yearNessun datoNessun dato

3.1yrs

Durata media

62.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di IOLCP sono considerati esperti (durata media dell'incarico 3.1 anni).

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2025/01/11 12:21
Prezzo dell'azione a fine giornata2025/01/10 00:00
Guadagni2024/09/30
Guadagni annuali2024/03/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* esempio per i titoli statunitensi, per quelli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più , cliccate qui.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su .

Fonti analitiche

IOL Chemicals and Pharmaceuticals Limited è coperta da 3 analisti. 2 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
null nullAntique Stockbroking Ltd.
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Kameswari V. S. ChavaliFirstCall Research